FDA NDC Directory · JSON-LD · Markdown

Atelvia

NDC 0430-0979 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Generic namerisedronate sodium
Labeler / ManufacturerAllergan, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022560
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsRISEDRONATE SODIUM HEMIPENTAHYDRATE (30.1 mg/1)
RISEDRONATE SODIUM MONOHYDRATE (4.9 mg/1)
Marketing started20101201
Package count1

External sources

Source: openFDA. Public-domain (CC0).